1956435-19-0 Usage
General Description
(R)-cyclobutyl(phenyl)methanamine hydrochloride is a chemical compound that belongs to the class of amines. It is a hydrochloride salt form of the medication, which is used as an antidepressant and a central nervous system stimulant. (R)-cyclobutyl(phenyl)methanamine hydrochloride acts by increasing the levels of certain neurotransmitters, such as serotonin and norepinephrine, in the brain, which helps to improve mood and relieve symptoms of depression. It is also thought to have potential in treating attention-deficit hyperactivity disorder (ADHD) and narcolepsy. However, the precise mechanism of action and full therapeutic potential of this compound are still being studied.
Check Digit Verification of cas no
The CAS Registry Mumber 1956435-19-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,5,6,4,3 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1956435-19:
(9*1)+(8*9)+(7*5)+(6*6)+(5*4)+(4*3)+(3*5)+(2*1)+(1*9)=210
210 % 10 = 0
So 1956435-19-0 is a valid CAS Registry Number.
1956435-19-0Relevant articles and documents
PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS
-
Paragraph 0082-0083; 0091-0092, (2015/01/07)
Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 26-27, (2010/04/23)
The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 46; 48, (2009/06/27)
Isoquinolone derivatives of the general formula are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
